We also showed that the methylation-mediated silencing of DLEC1 could be reversed by genetic or pharmacologic demethylation, and restoration of DLEC1 suppressed tumour cell clonogenicity, providing significant evidence that DLEC1 functions as a tumour suppressor in these tumours. The gene discussed is DLEC1; the disease is neoplasm.